CG Bio Co., Ltd. agreed to acquire 17.74846% stake in Innosys Co., Ltd. (KOSDAQ:A056090) from Smart Solutions Co., Ltd (KOSDAQ:A136510) for KRW24.5 billion on November 30, 2023. The transaction is expected to close on January 12, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11,600 KRW | -5.31% | -.--% | -.--% |
01/04 | Smart Solutions Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
07/02 | CG Bio Co., Ltd. completed the acquisition of Innosys Co., Ltd. from CG Bio Co., Ltd. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 491M | |
+23.54% | 362B | |
+16.81% | 120B | |
+43.65% | 110B | |
+10.75% | 20.01B | |
+11.85% | 20.15B | |
+38.08% | 10.39B | |
+46.69% | 10.74B | |
-1.47% | 8.07B | |
-23.11% | 6.14B |
- Stock Market
- Equities
- A136510 Stock
- News Smart Solutions Co., Ltd
- CG Bio Co., Ltd. agreed to acquire 17.74846% stake in Innosys Co., Ltd. from Smart Solutions Co., Ltd for KRW24.5 billion.